Basit öğe kaydını göster

Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial.

dc.contributor.authorCrowther, M
dc.contributor.authorPalumbo, Js
dc.contributor.authorKumar, R
dc.contributor.authorNurmeev, I
dc.contributor.authorHege, K
dc.contributor.authorBonnet, D
dc.contributor.authorConnor, P
dc.contributor.authorHooimeijer, Hl
dc.contributor.authorTorres, M
dc.contributor.authorChan, Akc
dc.contributor.authorKenet, G
dc.contributor.authorHolzhauer, S
dc.contributor.authorSantamaría, A
dc.contributor.authorAmedro, P
dc.contributor.authorChalmers, E
dc.contributor.authorSimioni, P
dc.contributor.authorBhat, Rv
dc.contributor.authorYee, Dl
dc.contributor.authorLvova, O
dc.contributor.authorBeyer-Westendorf, J
dc.contributor.authorMassicotte, Mp
dc.contributor.authorYoung, G
dc.contributor.authorPap, Af
dc.contributor.authorMajumder, M
dc.contributor.authorSmith, Wt
dc.contributor.authorHeubach, Jf
dc.contributor.authorBerkowitz, Sd
dc.contributor.authorThelen, K
dc.contributor.authorKubitza, D
dc.contributor.authorPrins, Mh
dc.contributor.authorMonagle, P
dc.contributor.authorEınsteın-Jr, Phase
dc.contributor.authorKállay, K
dc.contributor.authorGauger, Ca
dc.contributor.authorBiss, Tt
dc.contributor.authorMartinelli, I
dc.contributor.authorSaracco, P
dc.contributor.authorPeters, M
dc.contributor.authorMale, C
dc.contributor.authorLensing, Awa
dc.date.accessioned2021-03-05T13:24:49Z
dc.date.available2021-03-05T13:24:49Z
dc.identifier.citationMale C., Lensing A., Palumbo J., Kumar R., Nurmeev I., Hege K., Bonnet D., Connor P., Hooimeijer H., Torres M., et al., "Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial.", The Lancet. Haematology, cilt.7, 2020
dc.identifier.issn2352-3026
dc.identifier.othervv_1032021
dc.identifier.otherav_b2184c8f-cec2-45a3-bcb3-09c663a14a95
dc.identifier.urihttp://hdl.handle.net/20.500.12627/118647
dc.identifier.urihttps://doi.org/10.1016/s2352-3026(19)30219-4
dc.language.isoeng
dc.subjectSağlık Bilimleri
dc.subjectKlinik Tıp (MED)
dc.titleRivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial.
dc.typeMakale
dc.relation.journalThe Lancet. Haematology
dc.contributor.department, ,
dc.identifier.volume7
dc.contributor.firstauthorID2482026


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster